Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by scold79on Nov 22, 2016 1:15pm

83 Views

Post# 25496582

RE:RE:RE:GHG TOMRROW will be like NF Today, RUN HIGH

30seconds is just pumping. Been following GHG for a while now. And if you go to the GHG board 30seconds tells everyone how much they paid for shares and they are losing money. Just trying to get the volume up. Do some DD on GHG and you'll find the BC headquaters address is the address of an insurance company. (Google map it.) and if you check their last finacials release I think they showed $10,000.00 cash on hand. (I could be out a little on this.) And no news from them since the start on the year. So many red flags there. But do your own DD.

Bullboard Posts

Changing Europe’s dependency on HREE from China